
Adicet Announces FDA Clearance of IND Application for the Allogeneic CAR Gamma-Delta T Cell Therapy
Phase 1 Clinical Study will Evaluate ADI-001 Safety and Efficacy in Patients with B-cell non-Hodgkin’s lymphoma MENLO PARK, Calif. and...